Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis
- PMID: 17387214
- PMCID: PMC2092469
- DOI: 10.1136/thx.2006.060889
Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis
Abstract
With the improving survival of patients with cystic fibrosis (CF), the clinical spectrum of this complex multisystem disease continues to evolve. One of the most important clinical events for patients with CF in the course of this disease is an acute pulmonary exacerbation. Clinical and microbial epidemiology studies of CF pulmonary exacerbations continue to provide important insight into the course, prognosis and complications of the disease. This review provides a summary of the pathophysiology, clinical epidemiology and microbial epidemiology of a CF pulmonary exacerbation.
Conflict of interest statement
Competing interests: None.
Comment in
-
Pulmonary exacerbations in cystic fibrosis and bronchiectasis.Thorax. 2007 Apr;62(4):288-90. doi: 10.1136/thx.2006.065664. Thorax. 2007. PMID: 17387213 Free PMC article.
Similar articles
-
Acute Pulmonary Exacerbations in Cystic Fibrosis.Semin Respir Crit Care Med. 2019 Dec;40(6):792-803. doi: 10.1055/s-0039-1697975. Epub 2019 Oct 28. Semin Respir Crit Care Med. 2019. PMID: 31659730 Free PMC article. Review.
-
Diagnosis and Management of Cystic Fibrosis Exacerbations.Semin Respir Crit Care Med. 2023 Apr;44(2):225-241. doi: 10.1055/s-0042-1760250. Epub 2023 Feb 6. Semin Respir Crit Care Med. 2023. PMID: 36746183 Free PMC article. Review.
-
The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.Dev Period Med. 2015 Jan-Mar;19(1):66-79. Dev Period Med. 2015. PMID: 26003072
-
Background and Epidemiology.Pediatr Clin North Am. 2016 Aug;63(4):567-84. doi: 10.1016/j.pcl.2016.04.001. Pediatr Clin North Am. 2016. PMID: 27469176 Free PMC article. Review.
-
Update on cystic fibrosis epidemiology.Curr Opin Pulm Med. 2004 Nov;10(6):510-4. doi: 10.1097/01.mcp.0000138994.46519.72. Curr Opin Pulm Med. 2004. PMID: 15510059 Review.
Cited by
-
Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.Thorax. 2016 Mar;71(3):223-9. doi: 10.1136/thoraxjnl-2014-206750. Epub 2015 Apr 24. Thorax. 2016. PMID: 25911223 Free PMC article.
-
Combination antimicrobial susceptibility testing of multidrug-resistant Stenotrophomonas maltophilia from cystic fibrosis patients.Antimicrob Agents Chemother. 2012 Aug;56(8):4071-7. doi: 10.1128/AAC.00072-12. Epub 2012 May 14. Antimicrob Agents Chemother. 2012. PMID: 22585220 Free PMC article.
-
Treatment and demographic factors affecting time to next pulmonary exacerbation in cystic fibrosis.J Cyst Fibros. 2015 Nov;14(6):763-9. doi: 10.1016/j.jcf.2015.02.007. Epub 2015 Mar 6. J Cyst Fibros. 2015. PMID: 25754096 Free PMC article.
-
Role of inhaled antibiotics in the era of highly effective CFTR modulators.Eur Respir Rev. 2023 Jan 11;32(167):220154. doi: 10.1183/16000617.0154-2022. Print 2023 Mar 31. Eur Respir Rev. 2023. PMID: 36631132 Free PMC article. Review.
-
Pulmonary Exacerbations in Pediatric Patients: Retrospective Study in a Portuguese Cystic Fibrosis Center.Children (Basel). 2022 Jan 26;9(2):157. doi: 10.3390/children9020157. Children (Basel). 2022. PMID: 35204878 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical